Scholars Central

Conference abstractPublished 13 Jun 2016

Prognostic significance of N-glycolyl GM3 ganglioside expression in non-small cell lung carcinoma patients: New evidences

Authors: Adriana Carr Perez, Rances Blanco, Elizabeth Dominguez, Orlando Morales, Damian Blanco, Darel Martinez, Charles E Rengifo, Carmen Viada, Mercedes Cedeno, Enrique Rengifo

Center of Molecular Immunology, Cuba National Institute of Oncology, Cuba Manuel Fajardo Hospital, Cuba

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

NeuGcGM3 ganglioside is a human tumor specific antigen. The significance of NeuGc overexpression in human cancer is still under investigation. The prognostic role of N-glycolyl GM3 ganglioside (NeuGcGM3) expression in non-small cell lung carcinoma (NSCLC) still remains controversial. In this study, the NeuGcGM3 expression was reevaluated using an increased number of NSCLC cases and the 14F7 Mab (a highly specific IgG1 raised against NeuGcGM3). An immunohistochemical score integrating the percentage of 14F7-positive cells and the intensity of reaction was applied to reassess the relationship between NeuGcGM3 expression, some clinicopathological features and the overall survival (OS) of NSCLC patients. The double and the triple expression of NeuGcGM3 with the epidermal growth factor receptor (EGFR) and/or its ligand, the epidermal growth factor (EGF), were also evaluated. NeuGcGM3 expression correlates with both S-Phase fraction (p=0.006) and proliferation index (p=0.000). Additionally, NeuGcGM3 expression was associated with a poor OS of patients in both univariate (p=0.020) and multivariate (p=0.010) analysis. Moreover, the double and/or the triple positivity of tumors to NeuGcGM3, EGFR and/or EGF permitted us to identify phenotypes of NSCLC with a more aggressive biological behavior. Our results are in agreement with the negative prognostic significance of NeuGcGM3 expression in NSCLC patients. However, standardization of techniques to determine the expression of NeuGcGM3 in NSCLC as well as the implementation of a universal scoring system is recommended.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Cancer Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCancer Science & Therapy
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Adriana Carr Perez”
  • BylineArticles whose byline prints “Rances Blanco”
  • BylineArticles whose byline prints “Elizabeth Dominguez”
  • BylineArticles whose byline prints “Orlando Morales”
  • BylineArticles whose byline prints “Damian Blanco”
  • BylineArticles whose byline prints “Darel Martinez”
  • BylineArticles whose byline prints “Charles E Rengifo”
  • BylineArticles whose byline prints “Carmen Viada”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels